In a free society, individuals should be free to care for their physical well-being as they see fit, which includes the freedom to choose the medical treatments they think best. Such liberty does not open the door for fraud or abuse any more than does a free market in other products. In fact, informed consent by patients will become more sophisticated as the market for information about medical treatments becomes more free and open.

More on FDA and Drug Regulation

Commentary

On Guns and Opioids, Fear Is Driving Policy

By Jonathan Blanks and Jeffrey A. Singer. Washington Examiner. August 21, 2019.

Congress Needs to Settle the Looming Cannabis-Regulation Fight

By Ilya Shapiro and Randal John Meyer. National Review (Online). July 10, 2019.

‘Erectile Pricing’: Why Viagra’s Cost Defies the Laws of Economics

By Charles Silver and David A. Hyman. Houston Chronicle. June 23, 2019.

Cato Studies

Rational Self-Medication

By Michael E. Darden and Nicholas W. Papageorge. Research Briefs in Economic Policy No. 160. April 24, 2019.

Overdosing on Regulation: How Government Caused the Opioid Epidemic

By Jeffrey Miron, Greg Sollenberger, and Laura Nicolae. Policy Analysis No. 864. February 14, 2019.

Harm Reduction: Shifting from a War on Drugs to a War on Drug-Related Deaths

By Jeffrey A. Singer. Policy Analysis No. 858. December 13, 2018.

Articles

Today’s Nonmedical Opioid Users Are Not Yesterday’s Patients; Implications of Data Indicating Stable Rates of Nonmedical Use and Pain Reliever Use Disorder

Jeffrey A. Singer. Journal of Pain Research. Vol. 2,019. No. 12. February 7, 2019.

Drug Rebates Do Not Increase Costs to Consumers

Ike Brannon. SSRN Working Paper. May 29, 2018.

A Deadly Grip: Wisconsin’s Opioid Scourge: Its Origins and Possible Solutions

Ike Brannon and Devorah Goldman. Wisconsin Interest. Spring 2017.

Cato Reviews & Journals

Properly Valuing Gene Replacement Therapy

Ike Brannon and Anthony LoSasso. Regulation. Summer 2019.

The War on Drug-Related Deaths

Policy Report. May/June 2019.

USDA Reform: Help Rural America by Freeing Scientific Innovation

Amanda Maxham and Henry I. Miller. Regulation. Spring 2019.

Events

Patients, Privacy, and PDMPs: Exploring the Impact of Prescription Drug Monitoring Programs

Featuring Jeffrey A. Singer, David S. Fink, Kate M. Nicholson, Nathan Freed Wessler, & Patience Moyo. October 3, 2019. Policy Forum.

Harm Reduction: Shifting from a War on Drugs to a War on Drug-Related Deaths

Featuring Trevor Burrus, Clark Neily, Jeffrey A. Singer, Jeffrey Miron, Michael F. Cannon, Darwin Fisher, Edward G. Rendell, Maia Szalavitz, Donald S. Burke, Daniel Ciccarone, & Beau Kilmer. March 21, 2019. Conference.

Big Fat Nutrition Policy

Featuring Nina Teicholz and Terence Kealey. February 28, 2019. Policy Forum.